Tilaknagar Industries Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
TI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tilaknagar Industries reported consolidated revenue from operations of Rs 1,45,301.28 lakhs for Q3 FY26, up about 80% from Rs 80,534.86 lakhs in Q3 FY25, driven mainly by the newly acquired Imperial Blue business. For 9M FY26, revenue rose to Rs 3,23,247.13 lakhs from Rs 2,29,343.22 lakhs (around 41% growth). However, the company swung to a consolidated loss of Rs 10,540.84 lakhs in Q3 FY26 (vs a profit of Rs 5,392.66 lakhs a year ago) after booking Rs 16,942.06 lakhs (Rs 169.42 crores) as exceptional acquisition-related costs for the Imperial Blue deal. 9M FY26 profit dropped to Rs 3,577.67 lakhs from Rs 15,224.50 lakhs. Finance costs surged to Rs 3,924.59 lakhs in Q3 (from Rs 235.96 lakhs) due to acquisition borrowing. The auditor issued a qualified conclusion on the results, flagging that the company has not carried out the required impairment assessment of one of its ENA plants. The Imperial Blue acquisition from Pernod Ricard was completed on December 1, 2025 for Rs 3,442 crores, with an additional Rs 290 crores deferred after four years.
The sharp jump in revenue and scale is a long-term positive, but the quarterly loss, huge one-time acquisition cost, 16x rise in finance costs, and continued auditor qualification on ENA plant impairment may weigh on near-term stock sentiment. Investors should watch post-acquisition margin trends and integration of Imperial Blue over the coming quarters.